Buenos Aires - Delayed Quote ARS

Bristol-Myers Squibb Company (BMY.BA)

22,225.00

-1,275.00

(-5.43%)

At close: January 10 at 4:57:22 PM GMT-3

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis (NVS) CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline in areas like heart disease and cancer. Still, Narasimhan is feeling pressure to bring the investments to the bottom line to jumpstart its stock price.  In the last year, Novartis shares have declined 6.69%. During that same timespan, the S&P 500 and Dow Jones Industrial Average have gained 22.8% and 12%, respectively. The iShares U.S. Healthcare ETF (IYH) is up slightly in the past year. The stock prices of Pfizer (PFE) and Moderna (MRNA) are down 8.5% and 61%, respectively in the past year. For full episodes of Opening Bid, listen on your favorite podcast platform or watch on our website.

Yahoo Finance Video 2 days ago

PFE

NVS

NVSEF
Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade

Bristol Myers Squibb (BMY) concluded the recent trading session at $56.81, signifying a -0.58% move from its prior day's close.

Zacks 3 days ago

CELG-RT
How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products worldwide. It will report its Q4 2024 earnings on Feb. 6, 2025. Wall Street analysts expect the company to ...

Benzinga 3 days ago

CELG-RT
J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.

Zacks 3 days ago

JNJ

MDT

BSX
This Unpopular Dividend Stock Is a Buy

Like a champion boxer on the ropes, Bristol-Myers Squibb (NYSE: BMY) finds itself in a challenging position. Specifically, the pharmaceutical giant's shares have declined by a disappointing 11.6% over the prior five years while the benchmark S&P 500 has delivered total returns of 97.5%, including dividends. The company also continues to navigate generic competition for its cancer drug Revlimid, which it acquired as part of its 2019 deal for cancer specialist Celgene.

Motley Fool 3 days ago

CELG-RT
Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

Bristol Myers stock has performed well in the past year, gaining 11%. We believe there is more room for further growth, and any dip in the share price can be used as a buying opportunity.

Zacks 4 days ago

CELG-RT
Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?

We recently compiled a list of the Early Retirement Portfolio: 10 Stocks to Live Off Dividends. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks. As retirement approaches, ensuring financial stability becomes increasingly important for investors. Among the available investment options, consistent dividend payments […]

Insider Monkey 5 days ago

CELG-RT
Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Simply Wall St. 5 days ago

BMY

CELG-RT
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Filling your portfolio with dividend-paying stocks that raise their quarterly payouts faster than the underlying inflation rate could even lead to extra spending cash. Medtronic (NYSE: MDT), Bristol Myers Squibb (NYSE: BMY), and AbbVie (NYSE: ABBV) have many years of reliable dividend growth under their belts.

Motley Fool 8 days ago

ABBV

CELG-RT

MDT
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

Bristol Myers Squibb (BMY) closed the most recent trading day at $56.59, moving -0.35% from the previous trading session.

Zacks 9 days ago

CELG-RT

^GSPC
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

PRINCETON, N.J., January 03, 2025--Bristol Myers Squibb to Present at J.P. Morgan's 43rd Annual Healthcare Conference

Business Wire 9 days ago

BMY

CELG-RT
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025

(Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs. Drugmakers

PREMIUM
MT Newswires 9 days ago

CELG-RT

PFE
Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Simply Wall St. 10 days ago

BMY

CELG-RT
Corcept Submits Application for Another Cushing's Syndrome Drug

CORT makes pipeline progress with the submission of a new drug application for relacorilant to treat patients with endogenous hypercortisolism.

Zacks 12 days ago

CORT

CELG-RT
Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but […]

Insider Monkey 12 days ago

CELG-RT
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks 12 days ago

CELG-RT
Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?

We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands against the other long-term stocks. To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, […]

Insider Monkey 13 days ago

CELG-RT
FDA approves BMS’ Opdivo Qvantig for solid tumour indications

The approval for Opdivo Qvantig is based on the results from the Phase III CheckMate-67T trial.

Pharmaceutical Technology 13 days ago

CELG-RT
Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year

Bristol-Myers Squibb Company ( NYSE:BMY ) has announced that it will be increasing its dividend from last year's...

Simply Wall St. 14 days ago

BMY

CELG-RT
Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know

In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $57.68, denoting a -0.55% change from the preceding trading day.

Zacks 16 days ago

CELG-RT

Performance Overview

Return	BMY.BA	S&P 500
YTD	-0.56%	-1.35%
1-Year	+8.96%	+22.51%
3-Year	+405.22%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bristol-Myers Squibb Company (BMY.BA)

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

This Unpopular Dividend Stock Is a Buy

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?

Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025

Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years

Corcept Submits Application for Another Cushing's Syndrome Drug

Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?

Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?

FDA approves BMS’ Opdivo Qvantig for solid tumour indications

Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year

Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know

Performance Overview